BioCentury
ARTICLE | Company News

Amarin continues to slide on patent uncertainty

November 5, 2011 12:40 AM UTC

Amarin Corp. plc (NASDAQ:AMRN) fell $1.17 (14%) to $7.32 on Friday after the U.S. Patent and Trademark Office issued a non-final rejection letter for a patent application covering lead candidate AMR10...